主动脉瓣狭窄患者心肌纤维化与死亡率的性别特异性关联

IF 15.2 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS JAMA cardiology Pub Date : 2025-02-19 DOI:10.1001/jamacardio.2024.5593
Soongu Kwak, Anvesha Singh, Russell J. Everett, Thomas A. Treibel, Jaehyun Lim, Sungho Won, Michelle C. Williams, Krithika Loganathan, Rong Bing, Neil Craig, Trisha Singh, Shruti Joshi, Heesun Lee, Whal Lee, Yong-Jin Kim, Calvin W. L. Chin, Miho Fukui, Tarique Al Musa, Marzia Rigolli, Lionel Tastet, Laura E. Dobson, Stephanie Wiesemann, Vanessa M. Ferreira, Gabriella Captur, Sahmin Lee, Jeanette Schulz-Menger, Erik B. Schelbert, Marie-Annick Clavel, Sung-Ji Park, Costanza Pellegrini, Martin Hadamitzky, Bernhard L. Gerber, David E. Newby, Saul G. Myerson, Phillipe Pibarot, João L. Cavalcante, Gerry P. McCann, John P. Greenwood, James C. Moon, Marc R. Dweck, Seung-Pyo Lee
{"title":"主动脉瓣狭窄患者心肌纤维化与死亡率的性别特异性关联","authors":"Soongu Kwak, Anvesha Singh, Russell J. Everett, Thomas A. Treibel, Jaehyun Lim, Sungho Won, Michelle C. Williams, Krithika Loganathan, Rong Bing, Neil Craig, Trisha Singh, Shruti Joshi, Heesun Lee, Whal Lee, Yong-Jin Kim, Calvin W. L. Chin, Miho Fukui, Tarique Al Musa, Marzia Rigolli, Lionel Tastet, Laura E. Dobson, Stephanie Wiesemann, Vanessa M. Ferreira, Gabriella Captur, Sahmin Lee, Jeanette Schulz-Menger, Erik B. Schelbert, Marie-Annick Clavel, Sung-Ji Park, Costanza Pellegrini, Martin Hadamitzky, Bernhard L. Gerber, David E. Newby, Saul G. Myerson, Phillipe Pibarot, João L. Cavalcante, Gerry P. McCann, John P. Greenwood, James C. Moon, Marc R. Dweck, Seung-Pyo Lee","doi":"10.1001/jamacardio.2024.5593","DOIUrl":null,"url":null,"abstract":"ImportanceMyocardial fibrosis in aortic stenosis (AS) may exhibit sex differences. However, its prognostic significance in women with AS remains unclear.ObjectiveTo investigate sex differences in myocardial fibrosis assessed by cardiovascular magnetic resonance (CMR) and evaluate its prognostic value in women and men with AS.Design, Setting, and ParticipantsPatients with severe AS who underwent CMR before aortic valve replacement (AVR) were prospectively enrolled from 13 international sites between March 2011 and September 2021. Myocardial fibrosis was evaluated using extracellular volume fraction (ECV%) and late gadolinium enhancement (LGE). The main analysis was conducted on patients without obstructive coronary artery disease (CAD), defined as those with no history of myocardial infarction and no concomitant coronary artery bypass grafting. Data were analyzed from December 2023 to February 2024.ExposuresSurgical or transcatheter AVR.Main Outcomes and MeasuresThe primary outcome was post–AVR all-cause mortality and the secondary outcome was cardiovascular mortality.ResultsOf 822 patients, 670 were without obstructive CAD (368 men [55%] and 302 women [45%]). Among these, women and men had a similar age (median, 72 years vs 71 years, respectively), comorbidities, and AS severity. ECV% was similar between sexes; however, women had less LGE (both infarct and noninfarct LGE). After a median follow-up of 3.7 (IQR, 2.1-4.7) years, there were 76 deaths (11.3%), including 29 adjudicated cardiovascular deaths, in patients without obstructive CAD. Increasing ECV% and LGE were associated with higher all-cause and cardiovascular mortality in both sexes. Cox analyses demonstrated that both ECV% and LGE were associated with higher all-cause mortality without significant interaction by sex (women: adjusted hazard ratio [HR], 1.08 per 1% ECV% increase; 95% CI, 1.04-1.12; <jats:italic>P</jats:italic> &amp;amp;lt; .001; men: adjusted HR, 1.01; 95% CI, 0.96-1.06; <jats:italic>P</jats:italic> = .66; <jats:italic>P</jats:italic> for interaction by sex = .09 and women: adjusted HR, 2.49 for the presence of LGE; 95% CI, 1.07-5.80; <jats:italic>P</jats:italic> = .03; men: adjusted HR, 1.82; 95% CI, 1.00-3.32; <jats:italic>P</jats:italic> = .04; <jats:italic>P</jats:italic> for interaction by sex = .68). In the entire population (n = 822), both noninfarct and infarct-related LGE were associated with increased mortality without significant interaction by sex.Conclusions and RelevanceIn this study, patients with severe AS who underwent AVR exhibited similar ECV% between sexes, while women had lower LGE. Increased myocardial fibrosis provided important prognostic value for both sexes.","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":"2 1","pages":""},"PeriodicalIF":15.2000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sex-Specific Association of Myocardial Fibrosis With Mortality in Patients With Aortic Stenosis\",\"authors\":\"Soongu Kwak, Anvesha Singh, Russell J. Everett, Thomas A. Treibel, Jaehyun Lim, Sungho Won, Michelle C. Williams, Krithika Loganathan, Rong Bing, Neil Craig, Trisha Singh, Shruti Joshi, Heesun Lee, Whal Lee, Yong-Jin Kim, Calvin W. L. Chin, Miho Fukui, Tarique Al Musa, Marzia Rigolli, Lionel Tastet, Laura E. Dobson, Stephanie Wiesemann, Vanessa M. Ferreira, Gabriella Captur, Sahmin Lee, Jeanette Schulz-Menger, Erik B. Schelbert, Marie-Annick Clavel, Sung-Ji Park, Costanza Pellegrini, Martin Hadamitzky, Bernhard L. Gerber, David E. Newby, Saul G. Myerson, Phillipe Pibarot, João L. Cavalcante, Gerry P. McCann, John P. Greenwood, James C. Moon, Marc R. Dweck, Seung-Pyo Lee\",\"doi\":\"10.1001/jamacardio.2024.5593\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ImportanceMyocardial fibrosis in aortic stenosis (AS) may exhibit sex differences. However, its prognostic significance in women with AS remains unclear.ObjectiveTo investigate sex differences in myocardial fibrosis assessed by cardiovascular magnetic resonance (CMR) and evaluate its prognostic value in women and men with AS.Design, Setting, and ParticipantsPatients with severe AS who underwent CMR before aortic valve replacement (AVR) were prospectively enrolled from 13 international sites between March 2011 and September 2021. Myocardial fibrosis was evaluated using extracellular volume fraction (ECV%) and late gadolinium enhancement (LGE). The main analysis was conducted on patients without obstructive coronary artery disease (CAD), defined as those with no history of myocardial infarction and no concomitant coronary artery bypass grafting. Data were analyzed from December 2023 to February 2024.ExposuresSurgical or transcatheter AVR.Main Outcomes and MeasuresThe primary outcome was post–AVR all-cause mortality and the secondary outcome was cardiovascular mortality.ResultsOf 822 patients, 670 were without obstructive CAD (368 men [55%] and 302 women [45%]). Among these, women and men had a similar age (median, 72 years vs 71 years, respectively), comorbidities, and AS severity. ECV% was similar between sexes; however, women had less LGE (both infarct and noninfarct LGE). After a median follow-up of 3.7 (IQR, 2.1-4.7) years, there were 76 deaths (11.3%), including 29 adjudicated cardiovascular deaths, in patients without obstructive CAD. Increasing ECV% and LGE were associated with higher all-cause and cardiovascular mortality in both sexes. Cox analyses demonstrated that both ECV% and LGE were associated with higher all-cause mortality without significant interaction by sex (women: adjusted hazard ratio [HR], 1.08 per 1% ECV% increase; 95% CI, 1.04-1.12; <jats:italic>P</jats:italic> &amp;amp;lt; .001; men: adjusted HR, 1.01; 95% CI, 0.96-1.06; <jats:italic>P</jats:italic> = .66; <jats:italic>P</jats:italic> for interaction by sex = .09 and women: adjusted HR, 2.49 for the presence of LGE; 95% CI, 1.07-5.80; <jats:italic>P</jats:italic> = .03; men: adjusted HR, 1.82; 95% CI, 1.00-3.32; <jats:italic>P</jats:italic> = .04; <jats:italic>P</jats:italic> for interaction by sex = .68). In the entire population (n = 822), both noninfarct and infarct-related LGE were associated with increased mortality without significant interaction by sex.Conclusions and RelevanceIn this study, patients with severe AS who underwent AVR exhibited similar ECV% between sexes, while women had lower LGE. Increased myocardial fibrosis provided important prognostic value for both sexes.\",\"PeriodicalId\":14657,\"journal\":{\"name\":\"JAMA cardiology\",\"volume\":\"2 1\",\"pages\":\"\"},\"PeriodicalIF\":15.2000,\"publicationDate\":\"2025-02-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAMA cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1001/jamacardio.2024.5593\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamacardio.2024.5593","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

主动脉瓣狭窄(AS)的心肌纤维化可能表现出性别差异。然而,其在女性AS患者中的预后意义尚不清楚。目的探讨心血管磁共振(CMR)检测心肌纤维化的性别差异,并评价其在男性和女性AS患者中的预后价值。设计、环境和参与者:2011年3月至2021年9月期间,前瞻性地从13个国际站点招募了在主动脉瓣置换术(AVR)前接受CMR治疗的严重AS患者。采用细胞外体积分数(ECV%)和晚期钆增强(LGE)评价心肌纤维化。主要分析无阻塞性冠状动脉疾病(CAD)的患者,定义为无心肌梗死史,无合并冠状动脉搭桥术的患者。数据分析时间为2023年12月至2024年2月。手术或经导管AVR。主要结局和测量主要结局是avr后全因死亡率,次要结局是心血管死亡率。结果822例患者中670例无梗阻性CAD,其中男性368例(55%),女性302例(45%)。其中,女性和男性具有相似的年龄(中位数分别为72岁和71岁)、合并症和AS严重程度。两性间ECV%相似;然而,女性的LGE(包括梗死性和非梗死性LGE)较少。在中位随访3.7年(IQR, 2.1-4.7)年后,无阻塞性CAD患者中有76人死亡(11.3%),包括29例确诊心血管死亡。在两性中,ECV%和LGE的增加与更高的全因死亡率和心血管死亡率相关。Cox分析表明,ECV%和LGE均与较高的全因死亡率相关,性别间无显著相互作用(女性:调整后的危险比[HR],每1% ECV%增加1.08;95% ci, 1.04-1.12;P, amp;肝移植;措施;男性:调整后HR为1.01;95% ci, 0.96-1.06;P = .66;性别间相互作用的P = 0.09,女性间相互作用的校正HR为2.49;95% ci, 1.07-5.80;P = .03;男性:调整后的HR为1.82;95% ci, 1.00-3.32;P = .04;性别相互作用的P值= 0.68)。在整个人群中(n = 822),非梗死性和梗死相关性LGE均与死亡率增加相关,性别间无显著相互作用。结论和相关性在本研究中,重度AS患者行AVR后,两性间的ECV%相似,而女性的LGE较低。心肌纤维化增加对两性均有重要的预后价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Sex-Specific Association of Myocardial Fibrosis With Mortality in Patients With Aortic Stenosis
ImportanceMyocardial fibrosis in aortic stenosis (AS) may exhibit sex differences. However, its prognostic significance in women with AS remains unclear.ObjectiveTo investigate sex differences in myocardial fibrosis assessed by cardiovascular magnetic resonance (CMR) and evaluate its prognostic value in women and men with AS.Design, Setting, and ParticipantsPatients with severe AS who underwent CMR before aortic valve replacement (AVR) were prospectively enrolled from 13 international sites between March 2011 and September 2021. Myocardial fibrosis was evaluated using extracellular volume fraction (ECV%) and late gadolinium enhancement (LGE). The main analysis was conducted on patients without obstructive coronary artery disease (CAD), defined as those with no history of myocardial infarction and no concomitant coronary artery bypass grafting. Data were analyzed from December 2023 to February 2024.ExposuresSurgical or transcatheter AVR.Main Outcomes and MeasuresThe primary outcome was post–AVR all-cause mortality and the secondary outcome was cardiovascular mortality.ResultsOf 822 patients, 670 were without obstructive CAD (368 men [55%] and 302 women [45%]). Among these, women and men had a similar age (median, 72 years vs 71 years, respectively), comorbidities, and AS severity. ECV% was similar between sexes; however, women had less LGE (both infarct and noninfarct LGE). After a median follow-up of 3.7 (IQR, 2.1-4.7) years, there were 76 deaths (11.3%), including 29 adjudicated cardiovascular deaths, in patients without obstructive CAD. Increasing ECV% and LGE were associated with higher all-cause and cardiovascular mortality in both sexes. Cox analyses demonstrated that both ECV% and LGE were associated with higher all-cause mortality without significant interaction by sex (women: adjusted hazard ratio [HR], 1.08 per 1% ECV% increase; 95% CI, 1.04-1.12; P &amp;lt; .001; men: adjusted HR, 1.01; 95% CI, 0.96-1.06; P = .66; P for interaction by sex = .09 and women: adjusted HR, 2.49 for the presence of LGE; 95% CI, 1.07-5.80; P = .03; men: adjusted HR, 1.82; 95% CI, 1.00-3.32; P = .04; P for interaction by sex = .68). In the entire population (n = 822), both noninfarct and infarct-related LGE were associated with increased mortality without significant interaction by sex.Conclusions and RelevanceIn this study, patients with severe AS who underwent AVR exhibited similar ECV% between sexes, while women had lower LGE. Increased myocardial fibrosis provided important prognostic value for both sexes.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JAMA cardiology
JAMA cardiology Medicine-Cardiology and Cardiovascular Medicine
CiteScore
45.80
自引率
1.70%
发文量
264
期刊介绍: JAMA Cardiology, an international peer-reviewed journal, serves as the premier publication for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. As a member of the JAMA Network, it aligns with a consortium of peer-reviewed general medical and specialty publications. Published online weekly, every Wednesday, and in 12 print/online issues annually, JAMA Cardiology attracts over 4.3 million annual article views and downloads. Research articles become freely accessible online 12 months post-publication without any author fees. Moreover, the online version is readily accessible to institutions in developing countries through the World Health Organization's HINARI program. Positioned at the intersection of clinical investigation, actionable clinical science, and clinical practice, JAMA Cardiology prioritizes traditional and evolving cardiovascular medicine, alongside evidence-based health policy. It places particular emphasis on health equity, especially when grounded in original science, as a top editorial priority.
期刊最新文献
Left Atrial Structure and Function, Clinical Outcomes, and Efficacy of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy Maternal Cardiovascular Disease—Time to Close the Evidence Gap Ventricular Fibrillation With Intravascular Lithotripsy Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI Toward Precision Antiplatelet Therapy After Coronary Artery Bypass Grafting-Reply.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1